Stereoselective 1,4-Michael addition of azoimide to 17β-acetoxy-5α-adrost-1-en-3-one was carried out to furnish a 1α-azido-3-ketone, which was reduced to give the 3β- and 3α-hydroxy epimers in a ratio of 5â:â2. The Cu(I)-catalyzed 1,3-dipolar cycloaddition of the major isomer to terminal alkynes afforded 1α-triazolyl derivatives, which were deacetylated to the corresponding 3β,17β-diols or oxidized to the analogous 3-ketones. However, the ability of the minor 1α,3α-azidoalcohol to undergo similar cyclization was found to be affected significantly by the steric bulk of the substituents on the alkyne reaction partner. All triazolyl compounds were tested in vitro on three malignant gynecological cell lines (HeLa, MCF7 and A2780).
立体选择性的1,4-迈克尔加成反应将偶氮
亚胺加成到17β-乙酰氧基-5α-雄甾-1-烯-3-酮上,得到1α-
叠氮-3-酮,将其还原得到3β-和3α-羟基差向异构体,比例为5:2。
铜(I)催化的1,3-偶极环加成反应将主要异构体与端炔反应,形成1α-三唑基衍
生物,随后去乙酰化得到相应的3β,17β
-二醇,或氧化得到类似的3-酮。然而,次要的1α,3α-
叠氮醇进行类似环化的能力受到炔反应伴侣上取代基立体阻碍的显著影响。所有三唑基化合物都在体外对三种恶性妇科
细胞系(HeLa、MCF7和A2780)进行了测试。